Hisgade lands new funding round for glaucoma microstent

What's the deal? Hisgade (Suzhou) Biomedical Technology has closed a new funding round led by huaxing kangpingDealroom has a profile for this one. Try Dealroom →, the company announced in September 2026. The startup develops minimally invasive surgical solutions for glaucoma.

What's the endgame? Hisgade is building a full pipeline of products for the glaucoma field. Its lead candidate, the MicroCOGO trabecular meshwork microstent drainage system, has entered the clinical stage.

Why now? The MicroCOGO system targets early- and mid-stage patients with open-angle glaucoma. Fresh capital can help move that clinical-stage product further toward market.

The signal: Investor appetite for minimally invasive glaucoma devices reflects growing interest in the ophthalmology surgery market, where startups are racing to offer less invasive alternatives to traditional treatment.

Read more: itjuzi.com

Image credit: Generated with Gemini